We’re excited to share that our groundbreaking technology, Ultra Echo Scan, received a special award at the Masters&Robots 2025 startup competition.
The event, held under the honorary patronage of the Minister of Digital Affairs and backed by TVN Warner Bros. Discovery, recognizes forward-thinking solutions with global potential. The prize was accepted on behalf of our team by shareholder Piotr Ściegienka, who highlighted how meaningful this validation is for our mission. We thank the organizers and jury for supporting innovations that save lives, one heartbeat at a time.
We are proud to announce that Ultra Echo Scan (UES) won the grand prize at Start-Up-Med 2025, one of Poland’s most prestigious medical innovation competitions, held during the Health Challenges Congress.
The jury—composed of doctors, scientists, and technology leaders—recognized our AI-powered diagnostic system for its potential to transform neonatal cardiology.
This honor reinforces our belief that artificial intelligence can become a powerful ally in modern healthcare.
We are honored that UES was selected as the winner of the Mother and Child Startup Challenge 2024, the most important competition in Poland dedicated to medical startups.
This award validates years of hard work and confirms that UES fills a critical diagnostic gap in CHD detection.
We thank the Jury and organizers from the Institute of Mother and Child and look forward to contributing to the future of pediatric care.
Our project was selected as one of the top three finalists in the transformation partner category of the Children’s Hospital of the Future competition, organized by the K.I.D.S. Foundation.
UES was recognized for its innovative technology and potential to reshape the quality of care in pediatric hospitals.
We are grateful for this opportunity and hope it will bring further awareness to the life-saving potential of our solution.
Ultra Echo Scan qualified for the prestigious StartSmart CEE acceleration program – formerly MIT Enterprise Forum CEE.
This gives us access to global mentors, investors, and possibly the Boston Bootcamp, helping expand our reach beyond Europe.
As a deeptech company, we believe global thinking and strategic internationalization are essential to achieving true impact in medical innovation.